Compounds > neurotensin (8-13)
Page last updated: 2024-09-03

neurotensin (8-13) and sr 48692

neurotensin (8-13) has been researched along with sr 48692 in 4 studies

Compound Research Comparison

Studies
(neurotensin (8-13))		Trials
(neurotensin (8-13))		Recent Studies (post-2010)
(neurotensin (8-13))		Studies
(sr 48692)		Trials
(sr 48692)		Recent Studies (post-2010) (sr 48692)
66010203336

Protein Interaction Comparison

ProteinTaxonomyneurotensin (8-13) (IC50)sr 48692 (IC50)
Neurotensin receptor type 1Rattus norvegicus (Norway rat)0.082
Neurotensin receptor type 1Homo sapiens (human)0.0415
SortilinHomo sapiens (human)0.238

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinnock, RD; Woodruff, GN1
Antonelli, T; Ferraro, L; Fuxe, K; O'Connor, WT; Tanganelli, S1
Belmeguenai, A; Cavelier, F; Leprince, J; Louiset, E; Martinez, J; Vaudry, H; Vivet, B1
Kalivas, PW; Torregrossa, MM1

Other Studies

4 other study(ies) available for neurotensin (8-13) and sr 48692

ArticleYear
The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
    Neuroscience letters, 1994, May-19, Volume: 172, Issue:1-2

    Topics: Action Potentials; Animals; Dopamine; Electrophysiology; In Vitro Techniques; Male; Neurons; Neurotensin; Peptide Fragments; Pyrazoles; Quinolines; Rats; Receptors, Neurotensin; Substantia Nigra

1994
Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
    The European journal of neuroscience, 1997, Volume: 9, Issue:9

    Topics: Animals; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Globus Pallidus; Male; Microdialysis; Neurotensin; Peptide Fragments; Perfusion; Pergolide; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin

1997
Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Neuroendocrinology, 2000, Volume: 72, Issue:6

    Topics: Adamantane; Animals; Cells, Cultured; GTP-Binding Protein alpha Subunits, Gq-G11; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Heterotrimeric GTP-Binding Proteins; Imidazoles; Ligands; Male; Mammals; Melanocytes; Membrane Potentials; Neurotensin; Patch-Clamp Techniques; Peptide Fragments; Pituitary Gland; Pyrazoles; Quinolines; Rana ridibunda; Receptors, Neurotensin; Signal Transduction; Thionucleotides

2000
Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:2

    Topics: Animals; Brain; Cocaine; Cocaine-Related Disorders; gamma-Aminobutyric Acid; Male; Motor Activity; Neurotensin; Peptide Fragments; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Self Administration

2008